In animal studies, the administration of antioxidants from the fetal period increases the number of cells in the hippocampus 18 , indicating that early intervention to circumvent the effect of oxidative stress may be important to improve the neurological prognosis
Regulatory status: BPC-157 is not FDA-approved and was scheduled for FDA advisory committee discussion in July 2026
A multicenter phase I/II trial showed significant efficacy of oral pan-HDAC inhibitor Abexinostat (45 mg/m twice daily, 7 days on/intermittent dosing) in relapsed follicular lymphoma, with a 64.3% ORR and 20.5-month median PFS
Our manufacturing operations are supported by modern facilities and equipment, and every stage of production from formulation and quality control to packaging is carried out under defined quality and safety procedures
Nicotinamide riboside with pterostilbene (NRPT) increases NAD+ in patients with acute kidney injury (AKI): a randomized, double-blind, placebo-controlled, stepwise safety study of escalating doses of NRPT in patients with AKI
